FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
This is the first update to the original CTS communication distributed on July 6th. As previously co...